Tag Archives: Novavax

#BIOABS16 Will Highlight Biotech Solutions to Combating Emerging Infectious Diseases


More than 60 percent of infectious diseases in humans are spread from animals, and 75 percent of the emerging human pathogens are also expected to be zoonotic. HIV and Ebola are modern day examples of viruses that originated in animals and spread to humans. Even though most zoonotic diseases are not as deadly as HIV/AIDS, all strain public health resources, and some harm a region’s economy and even threaten national security. The severity of the Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,

BIO Members Collaborate to Produce MERS Treatment


BIO member companies SAB Biotherapeutics, Inc. (SAB) and Novovax, Inc. teamed up with the University of Maryland School of Medicine and the Naval Medical Research Center to treat the deadly Middle East Respiratory Syndrome Coronavirus, known as MERS-CoV. Headquartered in Sioux Falls, S.D., SAB Biotherapeutics, Inc. is an established, biopharmaceutical company that is leading the science and manufacturing of immunoglobulin therapies. Novavax, a clinical-stage vaccine company, is headquartered in Gaithersburg, MD and currently has vaccine candidates to treat a variety of infectious Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Race to Develop H1N1 Vaccine

Execs from Inovio Biomedical Corporation and Novavax will be speaking at BIF about their experience in the race to develop a vaccine for H1N1. Below are a couple recent developments from these companies: Novavax Inc (NVAX.O) recently reported that its seasonal flu vaccine candidate, which uses virus-like particles, induced an immune response against H3N2, H1N1 and B and was well-tolerated in a mid-stage trial. Read the release. Inovio Biomedical Corp. (INO) said it will team up Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,